Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions

: Regulated Authorization for Biktarvy 50 mg/200 mg/25 mg film-coated tabletsmg powder for concentrate for solution for infusion 0 - XML Representation

Raw xml | Download



<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="authorization94a96e39cfdcd8b378d12dd4063065f90"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorization94a96e39cfdcd8b378d12dd4063065f90"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;authorization94a96e39cfdcd8b378d12dd4063065f90&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: EU/1/18/1289/001 (use: OFFICIAL)</p><p><b>subject</b>: <a href="MedicinalProductDefinition-mp2a9c4333cfd126f2e7b73ad3cafd6949.html">MedicinalProductDefinition/mp2a9c4333cfd126f2e7b73ad3cafd6949</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2018-06-21 13:28:17+0000</p><p><b>holder</b>: <a href="Organization-mah-715f8a161ed438d0584510e5b4512caa.html">Organization/mah-715f8a161ed438d0584510e5b4512caa</a> &quot;Gilead Sciences Ireland UC&quot;</p><p><b>regulator</b>: <a href="Organization-mra-1133a7374c78f1d40f41885344f06a5a.html">Organization/mra-1133a7374c78f1d40f41885344f06a5a</a> &quot;European Medicines Agency&quot;</p></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://spor.ema.europa.eu/pmswi"/>
    <value value="EU/1/18/1289/001"/>
  </identifier>
  <subject>🔗 
    <reference
               value="MedicinalProductDefinition/mp2a9c4333cfd126f2e7b73ad3cafd6949"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi"/>
      <code value="220000000061"/>
      <display value="Marketing Authorisation"/>
    </coding>
  </type>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
      <display value="Active"/>
    </coding>
  </status>
  <statusDate value="2018-06-21T13:28:17Z"/>
  <holder>🔗 
    <reference value="Organization/mah-715f8a161ed438d0584510e5b4512caa"/>
  </holder>
  <regulator>🔗 
    <reference value="Organization/mra-1133a7374c78f1d40f41885344f06a5a"/>
  </regulator>
</RegulatedAuthorization>